Literature DB >> 17055620

The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease.

William P Hausdorff1.   

Abstract

A small number of serotypes are responsible for most invasive pneumococcal disease in children worldwide. Serotypes 1 and 5 were among the first pneumococcal serotypes to be identified, reflecting their great prominence as causes of disease in the early part of the 20th century. In the antibiotic era, these serotypes persist as important causes of disease in children in most countries even though they, unlike some other common serotypes, remain sensitive to antimicrobial agents. These types also exhibit a high level of virulence, cause disease clusters or outbreaks, infect all age groups, and cause severe disease. Future vaccine formulations that protect against these types are important for developed and developing countries alike.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055620     DOI: 10.1016/j.vaccine.2006.09.009

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  27 in total

1.  Molecular typing of pneumococci for investigation of linked cases of invasive pneumococcal disease.

Authors:  Bruno Pichon; Laura Moyce; Carmen Sheppard; Mary Slack; Deborah Turbitt; Richard Pebody; David A Spencer; Justin Edwards; Daniel Krahé; Robert George
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

2.  Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine.

Authors:  N Grall; O Hurmic; M Al Nakib; M Longo; C Poyart; M-C Ploy; E Varon; J Raymond
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-18       Impact factor: 3.267

3.  Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers.

Authors:  Susanna Esposito; Susan Tansey; Allison Thompson; Ahmad Razmpour; John Liang; Thomas R Jones; Giuseppe Ferrera; Alessandro Maida; Gianni Bona; Caterina Sabatini; Lorenza Pugni; Emilio A Emini; William C Gruber; Daniel A Scott; Nicola Principi
Journal:  Clin Vaccine Immunol       Date:  2010-04-28

Review 4.  Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines.

Authors:  Tina Q Tan
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

5.  Serotype 5 pneumococci causing invasive pneumococcal disease outbreaks in Barcelona, Spain (1997 to 2011).

Authors:  Dora Rolo; Asunción Fenoll; Dionísia Fontanals; Nieves Larrosa; Montserrat Giménez; Immaculada Grau; Román Pallarés; Josefina Liñares; Carmen Ardanuy
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

Review 6.  Childhood pneumococcal disease in Africa - A systematic review and meta-analysis of incidence, serotype distribution, and antimicrobial susceptibility.

Authors:  Pui-Ying Iroh Tam; Beth K Thielen; Stephen K Obaro; Ann M Brearley; Alexander M Kaizer; Haitao Chu; Edward N Janoff
Journal:  Vaccine       Date:  2017-03-09       Impact factor: 3.641

7.  Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine.

Authors:  Paul Balmer; Ray Borrow; Jamie Findlow; Rosalind Warrington; Sarah Frankland; Pauline Waight; Robert George; Nick Andrews; Elizabeth Miller
Journal:  Clin Vaccine Immunol       Date:  2007-09-19

8.  Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007.

Authors:  A Fenoll; J J Granizo; L Aguilar; M J Giménez; L Aragoneses-Fenoll; G Hanquet; J Casal; D Tarragó
Journal:  J Clin Microbiol       Date:  2009-02-18       Impact factor: 5.948

9.  Report on invasive disease and meningitis due to Haemophilus influenzae and Streptococcus pneumonia from the Network for Surveillance of Pneumococcal Disease in the East African Region.

Authors:  Sandra Mudhune; Maranga Wamae
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

10.  Pediatric parapneumonic empyema, Spain.

Authors:  Ignacio Obando; Carmen Muñoz-Almagro; Luis A Arroyo; David Tarrago; David Sanchez-Tatay; David Moreno-Perez; Sahar S Dhillon; Cristina Esteva; Susanna Hernandez-Bou; Juan J Garcia-Garcia; William P Hausdorff; Angela B Brueggemann
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.